CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline Jan 13, 2020 8:00am EST
CNS Pharmaceuticals Partnered with Anthem Biosciences Pvt. Ltd. in Preparation for Upcoming Proposed Phase 2 Clinical Trial Dec 17, 2019 8:00am EST
CNS' Berubicin Awarded $5.8 Million Non-Dilutive Grant from EU/Polish National Center Through its Development Partner Dec 11, 2019 8:00am EST
CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event Dec 09, 2019 8:00am EST
CNS Pharmaceuticals to Participate in 12th Annual LD Micro Main Event Conference Dec 03, 2019 8:00am EST
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals Nov 26, 2019 8:00am EST
CNS Pharmaceuticals Announces Attendance at the 24th Annual Meeting of the Society of Neuro-Oncology Nov 20, 2019 8:00am EST
